A Prospective, Single-Arm, Multi-Center Study of the Metavention Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects

• Age ≥22 and ≤70 years old

• Type 2 diabetes diagnosis meeting the following criteria:

‣ HbA1c \> 7.0% and ≤ 9.0% (53 mmol/mol - 75 mmol/mol), AND

⁃ On at least two anti-diabetic medications; one at the highest tolerated dose with no changes in medication dose in the 12 weeks prior to the first screening visit

• Waist circumference ≥102 cm (male) and ≥88cm (female)

• Diagnosis of hypertension: SBP ≥140mmHg OR SBP ≥130mmHg on hypertension medication(s)

• Documented status of stable lifestyle modifications

• Women of childbearing potential (WOCBP) must be using at least one acceptable method of contraception throughout the study